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INTRODUCTION
“The  omission  of  predictions  form  the  major  goals  of  basic  medical 
science  has  impoverished  the  intellectual  content  of  clinical  work  since  a 
modern  clinician’s  main  challenge  in  the  care  of  patients  is  to  make 
predictions”.
        Accurate prognosis is critical to the improvement of medical practice, the 
purpose of which is to improve patient survival. An accurate predictive ability 
would make it possible to measure more precisely, the value of intensive care 
and other new life-saving technologies. Precise prognosis or risk stratification 
before  treatment  would  also  enable  clinical  researchers  to  use  natural 
experiments or observational studies to contrast the quality of care in various 
intensive care units (ICUs) and to identify those components of ICU structure 
and  process  that  are  linked  to  improved  patient  outcome.  Such  information 
could lead to changes in clinical decision-making that would improve overall 
ICU use, enhance patient satisfaction and guide the rational allocation of health 
care resources.  It was progress towards these goals that inspired development 
of severity grading systems. 
Many scoring systems have been designed and used successfully to grade 
the severity of acute peritonitis and intra-abdominal  sepsis.  The most  widely 
used  index,  APACHE  II  (Acute  Physiological  and  Chronic  ill  Health 
Evaluation),  was  developed  from a  group  of  medical  and  surgical  patients. 
Although  not  specifically  designed  for  general  surgical  practice  it  has  been 
successfully  used  by  many  authors  to  assess  critically  ill  general  surgical 
patients.  It  has  also  been  compared  with  other  scoring  systems  with  good 
results.
Generalized peritonitis is the most common surgical emergency in India. 
Despite  advances  in  surgical  techniques,  antimicrobial  therapy and intensive 
care  support,  management  of  peritonitis  continues  to  be  highly  demanding, 
difficult and complex. The spectrum of etiology of peritonitis continues to be 
different from that of western countries and there is paucity of data from India 
regarding  its  etiology,  prognostic  indicators,  and  mortality  and  morbidity 
patterns.
 In our study, we propose to use the modified APACHE II scoring system 
to assess the patients attending our hospital with generalized peritonitis.
REVIEW OF LITERATURE
Throughout  the  evolution  of  surgery,  intra-abdominal  infections  have 
been  a  continuous  diagnostic  and  therapeutic  challenge.  Even  with  the 
availability  of  advanced  and  sophisticated  medical  technology  today,  this 
remains true. Until the end of the last century, intra-abdominal infections were 
treated non-surgically,  and the mortality  was 90 percent.  Today, we are  not 
quite sure about the mortality risk and reports range from 0 to 50 percent3.
      The past decade has seen a burst of activity and investigation into the 
pathophysiology, diagnosis and treatment of severe surgical infections. This has 
included  many  clinical  reports  as  well  as  basic  laboratory  pursuits  of  the 
underlying  pathophysiologic  mechanisms  of  bacterial  infection,  bacterial 
virulence factors and the nature of the host response. The greatest efforts have 
been directed towards intra-abdominal infections.
        During the same period, the variety and potency of antibiotics available 
have  increased  dramatically,  and  technical  aspects  of  surgical  respiratory 
support,  organ replacement,  and pharmacologic  support in the intensive care 
unit have improved. Many publications have evaluated the efficacy of one or 
more of these treatment  modalities.  Although promising advances have been 
made,  many  reports  do  not  include  contemporaneous  prospectively  enrolled 
control groups. Even in those studies that do control treatments, the description 
of  the patients  is  often insufficient  to allow precise  comparison with patient 
groups in other centers.
          When  considering  intra-abdominal  infections,  the  complexities  of  the 
disease process and of the host response make comparison of patients difficult. 
Definition of disease by one definition may differ dramatically in the severity of 
infection  and  in  the  host  response  to  it.  Our  ability  to  support  critically  ill 
patients  for  long periods of  time in the intensive care unit  provides us with 
patients in whom the complexity of the disease and its therapy make it very 
difficult for even an expert clinician to predict outcome correctly.
        Over the years,  physicians have used a number  of indices to describe 
patients with comparable extents of disease more precisely and reproducibly. 
This  has  been most  extensively  developed in the field of  cancer,  where are 
specific systems for different tumours such as Duke’s classification for rectal 
cancer,  the Columbia classification for breast  cancer,  the Clark and Breslow 
systems  for  melanoma  and  the  more  generalized  tumour-node-
metastases(TNM) system for  cancers  in  general.  Facial  fractures,  epiphyseal 
fractures,  and open long-bone fractures  all  have  classification  schemes.  The 
degree of coma following head injury, several trauma scores, burn indices, a 
nutritional  index,  Forrester’s  classification  of  acute  myocardial  infarction, 
Ranson`s  criteria for acute pancreatitis, and Child-Turcotte classification for 
liver disease are all used.
     Scoring  systems  had  been  found  useful  in  predicting  the  outcome  in 
critically ill patients, thus allowing application of resources for effective use. 
The prognosis in peritonitis is decisively influenced by the health status of the 
patient at the beginning of the treatment and by any concomitant risk factors. 
Since 1983, a  number  of  systems designed to measure the severity  of 
surgical infections have been published. The following is a brief description of a 
few of these systems.
SCORING SYSTEMS
THE APACHE SYSTEM:
       In  1981,  Knaus  and others  proposed a  scoring  system to  be  used for 
classifying patients admitted to intensive care units4. It consisted of two parts:
1. A physiology score representing the degree of severity of acute illness 
( the Acute Physiology Score)
2. A preadmission health evaluation indicating a patient’s health status 
before the acute illness.
     The  APS  was  developed  using  an  expert  panel  of  multidisciplinary 
physicians  who  selected  laboratory  and  clinical  measurements  important  in 
predicting mortality5.  They restricted the selection  to  physiological  variables 
that  were  available  or  obtainable  on  or  shortly  after  admission  to  an  ICU. 
Relative weights of importance were assigned so each variable was weighted on 
the basis of its degree of abnormality and its relative importance compared with 
all  its  other  measurements.  Each physician in the group was free to suggest 
additions or  deletions of variables included on an initial  list.  Ultimately,  the 
panel agreed on a list of 34 physiological measurements, and relative weights of 
importance  were  assigned  on  a  scale  from 0  to  4.  The  weights  are  neither 
symmetrical around the normal range nor uniform across different physiological 
measures.
      In the original APACHE system, the greatest degree of abnormality for 
each  physiological  variable  recorded  within  the  initial  32  hours  after  ICU 
admission  was  used  to  create  the  score.  Although  32  hours  did  allow  for 
potential effect of therapy on physiology to be introduced, it provided time for 
all potential data to be available. The original APS for a patient was the total 
points for all 34 variables.
       The second part of the original APACHE was the health questionnaire 
that  assessed  health  status  before  admission.  On  the  basis  of  answers  to 
questions regarding 1) number of recent visits to a physician, 2) work status, 
3)activities of daily living and 4) presence of carcinoma, a patient was given a 
pre- ICU admission classification ranging from `A` for excellent health and `D` 
for severe failing health. The end result of APACHE was a separate APS and 
chronic disease classification for each patient. (E.g.: 14D, 16C etc.)2.
ACUTE PHYSIOLOGY SCORE
Points +4 +3 +2 +1 0 +1 +2 +3
Heart rate ventricular response 180 or > 141-179 111-140 70-110 56-69 41-55
Mean blood pressure (mm Hg) 160 or > 131-159 111-130 70-110 51-69
Rt. atrial pressure, CVP (mm Hg)  26 or > 16-25 1-15 <1
CPK –MB & ECG evidence of acute Ml Yes No
Atrial arrhythmias + 
hemody namic 
instability
Atrial 
arrhythmias alone
>6 PVCs/min
Lactate mEq/L (Serum) >8 3.5-8 0-3.4
7.7 or > 7.6-7.69 7.51-7.59 7.33-7.5 7.25-7.32 7.15-7.24
Respiratory rate total non-ventilated 50 or > 35-49 26-34 12-25 10-11 7-9
>500 351-499 200-350 <200
70 or > 61-69 50-60 30-49 25-29 20-24
5 L or > 3501-4999 ml 700-3500ml 480-699ml 
(20-29ml/h)
120-479ml 
(5-20ml/h)
>150 101-150 81-100 21-80 10-20 <10
>8 3.6-7 2.1-3.5 1.6-2 0.16-1.5 <0.6
se international units 2000 or > 500-1999 < 500 
>8 3.5-8 2.5-3.4 <2.5
15 or > 5.1-14.9 0-5
ALKP phosphastase (serum) international >160 0-160
1500 or > 101-1499 0-100
Total Relative None
>60 51-60 47-50 30-46 20-29
WBC-White blood count (total) >40,000 20,001-40,000 15,001-20,000 3000-15,000 1000-2999
>1,000,000 600,001-1,000,000 80,000-6,00,000 20,000-79,999
ec> Control) no anticoagulants >12 5.1-12 3.1-5 0-3
Yes No
Yes No
Blood and/or 
CSF
2 sites other than blood 
or CSF
1 site other than 
blood or CSF
None
>41.0 39.1-41.0 38.6-39.00 36.0-38.5 34.0-35.9 32-33.9 30.0-31.9
Serum calcium mg/100ml 16 or > 14-15.9 11.1-13.9 8-11.0 5.0-7.9
>800 500-800 251-499 70-250 50-69 30-49
>180 161-180 156-160 151-155 130-150 120-129 110-119
>7 6.1-7 5.6-6 3.5-5.5 3-3.4 2.5-2.9
>40 31-40 20-30 10-19 5-9
>350 321-350 301-320 260-300 240-259 220-239
3 4-6 7-9 10-12 13-15
 P(A-a) O2 = FiO2 (713) – PaCO2 – PaO2
 Total anergy - no response to all provocative skin tests including mumps and  fungal. Relative – reduced to skin tests 
indicative of compromised cellular immunity. 
Qualifying Questions, based on health status 3-6 months before 
admission
Group Description
Did the patient have weekly visits to a physician?
Was the patient unable to work because of illness?
Was the patient bedriddent or institutionalized because of illness?
Had the patient suffered a relapse after systemic treatment for carcinoma?
D
Severe restriction of activity due to 
disease; includes patients bedridden or 
institutionalized due to illness
Was the patient's usual daily activity limited?
Did symptoms occur with mild exercise?
Had the patient received treatment for neoplasm with remission?
Had the patient received uncomplicated hemodialysis?
C
chronic disease producing serious but not 
incapacitating restriction of activity
Did the patient see a physician monthly? 
Did the patient take medication chronically?
Was the patient mildly limited in activity level due to illness?
Did the patient have diabetes mellitus, chronic renal failure, a bleeding 
disorder, or chronic anemia?
B
mild to moderate limitation in activity 
because of chronic health problem
Negative responses to all of the above questions
A
prior good health with no functional 
limitations
Results with APACHE in the initial study group of 582 patients at 
George  Washington  University  medical  centre,  demonstrated  a  direct 
relationship between the APS and the probability of death, a relationship that 
was duplicated in independent studies6,  7,  8. Health status before admission 
was  directly  related  to  outcome.  Only  the  pre-admission  class  ‘D’ 
designation was independently associated with an increased mortality risk5.
THE APACHE II SYSTEM:
      The APACHE II system is a revised version of the original APACHE 
and was published in1985. The number of physiologic measurements was 
reduced  from  the  original  34  to  12.  Infrequently  measured  physiologic 
variables such as serum osmolarity, lactic acid level, and the skin testing for 
anergy were deleted, as were potentially redundant variables. Each variable 
was  deleted  based  upon  clinical  judgement  and  then  evaluated  using  a 
multivariate  comparison  of  the  original  APACHE  system  with  each 
proposed revision, the total R2 and the correct classification rate for hospital 
mortality  were  used  standards.  The  smallest  number  of  variables  that 
reflected  physiologic  derangement  for  all  vital  organ systems  as  well  as 
maintained statistical precision was 12.
    Age  and  severe  chronic  health  problems  reflect  diminished 
physiologic  reserve  and  hence  they  have  been  directly  incorporated  into 
APACHE II.  Chronologic age is a well-documented risk factor  for death 
from acute illness that is independent of the severity of disease. 
     
THE APACHE II SCORING
HIGH ABNORMAL RANGE LOW ABNORMAL RANGE
PHYSIOLOGIC VARIABLE 4 3 2 1 0 1 2 3 4
Temperature rectal(oC) ≥41 39-40.9 38.5-38.9 36-38.4 34-35.9 32-33.9 30-31.9 ≤29.9
Mean arterial pressure (mmHg) ≥160 130-159 110-129 70-109 50-69 ≤49
High rate (ventricular response) ≥150 140-179 110-139 70-109 55-69 40-54 ≤39
Respiratory rate ≥50 35–49 25–34 12–24 10–11 6–9 <5
Oxygenation Pao2 (mmHg) ≥500 350-499 200-349 <200
Arterial pH ≥7.7 7.6-7.69 7.5-7.59 7.33-7.49 7.25-7.32 7.15-7.24 <7.15
Serum sodium mMol/L ≥180 160-179 155-159 150-154 130-149 120-129 111-119 <110
Serum potassium mMol/L ≥3.5 2-3.4 1.5-1.9 0.6-1.4 <0.6
Haemtocrit % ≥60 50-59.9 46-49.9 30-45.9 20-29.9 ,20
WBC x 1000 (total mm3) ≥40 20-39.9 15-19.9 3-14.9 1-2.9 <1
Serum HCO3 Venous blood mMol ≥52 41-51.9 32-40.9 22-31.9 18-21.9 15-17.9 <15
Glasgow coma score= 15-actual GCS
          
AGE POINTS:  <44 = 0; 45-54 = 2; 55-64 = 3; 65-74 = 5; ≥75 =  6.
Chronic ill-health evaluation (severe organ insufficiency) Points:  presence of chronic illness requiring the 
following :
(a)    for non-operative or emergency postoperative patients – 5
           (b) for elective postoperative patients – 2 
During  the  validation,  it  was  found  that  three  of  the  four  chronic 
health classifications (B, C, and D) were associated with higher death rates, 
when age  and  acute  physiologic  derangement  were  controlled.  However, 
only  the  most  severe  chronic  organ  system  insufficiency  or 
immunocompromised state (Class D) markedly influenced outcome. It was 
also discovered that non-operative and emergency surgery admissions had a 
substantially  higher  risk  for  death  from  their  prior  organ  system 
insufficiency than elective surgical admissions. This was probably because 
patients with the most severe chronic conditions were not considered to be 
candidates  for  elective  surgery.  Therefore  non-  operative  or  emergency 
operative admissions with a severe chronic organ system dysfunction were 
given an additional five points, while similar elective surgical admissions 
were given only two points. The maximum possible APACHE II score is 
719.
THE SIMPLIFIED ACUTE PHYSIOLOGICAL SCORE (SAPS):
This system was developed by Le Gall et al in 1984 as an independent 
attempt to simplify APACHE. A multiple regression technique was used to 
select  13  variables  namely  age;  heart  rate;  systolic  blood  pressure; 
temperature; respiratory rate; urine output; blood urea nitrogen; hematocrit; 
white blood cell count; serum glucose, potassium, and sodium levels; and 
Glasgow  coma  score.  The  initial  score  was  calculated  using  the  most 
abnormal  value within the initial  24 hours of ICU admission.  To a large 
extent, the same weights used in the original APACHE system were used2.
       Comparisons have been made of the relative predicted accuracy of 
SAPS versus APACHE II,  both in multidiagnostic  data  bases and within 
specific disease categories6,8,10. The results indicate that there is a measurable 
improvement  in  predictive  accuracy,  defined  as  percent  area  under  a 
Receiver-Operator Characteristic curve, for APACHE II as compared with 
SAPS  when  the  comparison  was  performed  with  multidiagnostic  data. 
However, when comparisons were made within a single diagnostic category 
virtually equal accuracy was observed. The difference between these results 
is explained by the differences in the systems. SAPS produces probability 
estimates  without  use  of  specific  diagnostic  or  chronic  health  variables, 
therefore comparisons  between it  and APACHE II  (which does use both 
these  additional  variables)  should  favour  APACHE  II.  Within  a  single 
diagnostic category, however the two systems are similar enough in design 
that  large  sample  sizes  are  necessary  to  detect  differences  in  predictive 
accuracy2.
THE APACHE III PROGNOSTIC SYSTEM:
This system was developed by Knaus et al in 1991 with an objective 
to  refine  the  APACHE methodology  in  order  to  more  accurately  predict 
hospital  mortality  risk  for  critically  ill  hospitalized  adults.  This  system 
consists of two options: 1) an APACHE III score, which can provide initial 
risk stratification for severely ill hospitalized patients within independently 
defined patient groups; and 2) an APACHE III predictive equation, which 
uses APACHE III score and reference data on major disease categories and 
treatment  location  immediately  prior  to  ICU  admission  to  provide  risk 
estimates for hospital mortality for individual ICU patients.
     The  scores  and  the  equation  were  formulated  after  analyzing  data 
collected prospectively form 17,440 unselected adult medical and surgical 
intensive care unit admission at 40 U.S. hospitals. Analysis was carried out 
to  study the relationship between the patient’s  likelihood of surviving to 
hospital discharge and the following predictive variables: major medical and 
surgical  disease  categories,  acute  physiologic  abnormalities,  age,  pre-
existing functional limitations, major co morbidities and treatment location 
immediately prior to ICU admission.
   Results of this analysis showed that a five point increase in APACHE 
III score (range 0 to 299 ) was independently associated with a statistically 
significant increase in the relative risk of hospital death ( Odds ratio 1.10  to 
1.78) within each of 78 major medical and surgical disease categories. The 
overall predictive accuracy of the first day APACHE III  equation was such 
that, within 24 hours of ICU admission, 95% of the patients could be given a 
risk estimate for hospital death that was within 3% of that actually observed 
(r2 =0.41).  Recording changes in the APACHE III score on each subsequent 
day of ICU therapy provided daily updates in these risk estimates11.
          Barie et al in a prospective study on 844 consecutive patients in the 
surgical  intensive  care  unit  comparing  the  APACHE  II  and  III  scoring 
system for predicting mortality, observed an overall mortality of 7% in the 
surgical  intensive  care  unit  and  9.1%  in  the  hospital.  The  relationship 
between APACHE II and III scores for individual patients was linear and 
correlated significantly (p< 0.0001). Overall and in all subgroups, both the 
scoring  systems  over-estimated  the  mortality,  but  estimations  made  by 
APACHE III were significantly (p< 0.01) higher.
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APACHE III SCORING FOR VITAL SIGNS AND LABORATORY TESTS
SEPSIS SCORE: 
             Developed by Elebute and Stober in 1983, this system divides the  
clinical features of the septic state into four classes to which they ascribed a 
subjective degree of severity on an analogue scale. The attributes were
1) Local effects of tissue infection,
2) Degree of temperature elevation,
3) Secondary effects of sepsis and 
4) Laboratory data.
          The possible range of scores under this system is 0 to atleast  45, 
depending on how the tables are interpreted. This system has been examined 
in detail by Dominioni and associates. They reported on 135 patients with 
broad  variety  of  infectious  problems,  including  peritonitis,  pneumonia, 
wound  infection,  urinary  tract  infection,  abscess,  septicemia  and 
mediastinitis. The sepsis scores ranged from 10 to greater than 30. In a group 
of patients with an overall mortality rate of 56%, they observed deaths of 13 
of 64 patients (20%) with scores of 20 or below and 63 of 71(89%) with 
scores greater than20. if a score of 20 is arbitrarily chosen as a point above 
 SEPSIS SCORE
SCORING OF LOCAL  EFFECTS OF TISSUE INFECTION SCORING OF SECONDARY EFFECTS OF SEPSIS
Attribute Score Attribute Score
Wound infection with purulent / enterocutaneous fistula 
Requiring only light dressing changed not more than once daily. 
Requiring to be dressed with a pack, dressing needing to be  changed more than 
2 Obvious jaundice in the absence of established  hepatobiliary disease.
Metabolic acidosis 
Compensated    
2
1
     once daily, requiring application of a bag and/or requiring suction.  4 Uncompensated 2
Pemtonitis
Localized 
Generalized
2
6
Renal failure
Gross disturbance of mental orientation /level of consciousness (e.g. delirium., 
    coma)and /or other focal neurological manifestations of pyemia/septicemia 
    having excluded other causes. 
3
3
Chest infection 
Clinical or radiological sings of chest infection without productive cough 
Clinical or radiological signs of chest infection with a cough producing purulent sputum. 
2
4
Bleeding diathesis from  disseminated intravascular coagulation  3
Full clinical manifestations of lobar/ bronchopneumonia 
Deep – seated infection (e.g. subphrenic abscess. Pelvic abscess. empyema thoraces, acute  
     or chronic osteomyelitis)   
6
6
SCORING OF LABORATORY DATA
Attribute
Score
Blood culture
Single positive cultures 1
SCORING OF PYREXIA (ORAL TEMPERATURE) Two or more positive cultures separated by 24 hours  3
Attribute Score Single positive culture + history of invasive procedure 3
Single positive culture + cardiac murmur and/or tender enlarged spleen 3
Maximum daily temperature > (c0) 0 Leukocyte count (x 109/L) 
36-37.4 1 12-30 1
37.5-38.4 2 >30 2
38.5-39 3 <2.5 3
>39 3 Hemoglobin level in the absence of obvious bleeding (gm/dl) 
<36 Add 7-10 1
Minimum daily temperature >37.50c
If 2 or more temperature peaks above 38.40c in 1 day  
If any rigours occur in a day 
Temperature should be recorded at least 4 times in 24 hours; record for the period is   
     assessed as above and “pyrexia score” computed.  
1
1
1
>7
Platelet count (x 109/L) 
100-150
<100
plasma albumin level (gm/L)
31-35
25-30
<25
Plasma total bilirubin level in the absence of clinically obvious jaundice> 25 
mol/L 
2
1
2
1
2
3
1
Total score is sum of individual scores.  
which death is predicted, the overall accuracy for this prediction will be 114 
of 135 (84%). 
THE MANHEIM PERITONITIS INDEX:
Wacha  and  co-workers  developed  this  index  which  incorporates 
information  regarding  age,  gender,  organ  failure,  cancer,  duration  of 
peritonitis, involvement of the colon, extent of spread within the peritoneum 
and the character of the peritoneal fluid, to define risk.
The Manheim Peritonitis Index
Risk factor Weighing if present
Age > 50 years
Female sex
Organ failure*
Malignancy
Preopertative duration of peritonitis >24 h
Origin of sepsis not colonic
Diffuse generalized peritonitis
Exudate
   Clear
   Cloudy, purulent
   Faecal
5
5
7
4
4
4
6
0
6
12
* Definitions of organ failure
Kidney                                                 creatinine level > 117 mmo/L
                                                             Urea level > 167 mmol /L
                                                             Oliguria < 20ml / h
Lung                                                     Po2 < 50 mmHg
                                                             PCo2 > 50 mmHg
Shock(definition according to              Hyperdynamic or Hypodynamic
Shoemaker)
Intestinal obstruction ( only if              Paralysis > 24 h or complete 
 Profound)                                                 mechanical ileus
      The possible scores range from 0 to 47, and patients with score above 
26 are defined as having peritonitis4.
     Billing et al evaluated the effectiveness of this system in a multicenter 
study  involving  2003  patients.  The  overall  mortality  was  19.5%.  The 
maximal score was 47. 522 patients had a score of >26 and a mortality rate 
of 55% which was significantly greater than the 7% mortality observed in 
the 1481 patients who had a score of < 2613.
PERITONITIS INDEX ALTONA:
Teichmann and associates, in a report concerning scheduled reoperation for 
diffuse peritonitis, referred to this index. In this study, they observed that 
mean  pertionits  index  for  patients  who  died  was  1.59,  whereas  that  for 
patients  who  lived  was  0.38.  this  index  uses  age,  extent  of  infection, 
malignancy, cardiovascular risks, and leucopenia, to stratify patients4. 
POSSUM:
 Physiological  and  Operative  Severity  Score  for  enUmeration  of 
Mortality  and morbidity  (POSSUM) and its  Portsmouth  modification  (P-
POSSUM)  were  developed  to  provide  risk-adjusted  analysis  in  patients 
undergoing surgery. It consists of two parts:
Physiological assessment:
 It  provides  exponential  score  on  12  variables.  The  physiological 
variables are: age, cardiac signs, respiratory signs, systolic blood pressure, 
pulse, coma score, serum urea, sodium, potassium, haemoglobin, white cell 
count, and ECG.
Operative severity:
- operative magnitude
- number of operations within 30 days
- blood loss
- peritoneal contamination
- presence of malignancy
- timing of operation.
     This scoring system produced assessments for morbidity and mortality 
rates, which did  not significantly differ from observed rates and has been 
acknowledged as the most appropriate of the currently available scores for 
general surgical practice.
USES OF PROGNOSTIC SCORING SYSTEMS:
Prognostic scoring systems have proved useful in risk stratification of 
patients  for  clinical  trials  and  in  the  assessment  of  the  quality  of  care 
delivered  in  ICUs.  It  is  likely  that  they  will  assist  the  decision  process 
regarding ICU admission. The role they will ultimately have in individual 
patient care decisions remains to be determined
1.    Clinical studies:
A  central  problem  in  conducting  a  clinical  trial  with  acutely  ill 
patients is the need to ensure that both the treatment and control groups are 
at  an  equivalent  baseline  risk  of  death  or  another  important  outcome. 
Randomization  is  used to  spread these  risks  evenly  between the patients 
groups, but randomization can only ensure that patients, not their risks are 
randomly  distributed.  For  example,  in  the  evaluation  of  a  new  form of 
therapy for peritonitis, potential patients could range from a 19 year old with 
a  rupture  appendix  to  a  72  year  old  with  emphysema  and  cancer  of 
perforated colon. Appropriate conclusions regarding the efficacy of a new 
peritonitis  treatment  could  not  be  reached  unless  the  patients  and  their 
accompanying risks were evenly distributed between treatment and control 
groups. A prognostic scoring system permits investigators to stratify patients 
according  to  risk  before  randomization  to  ensure  that  risks  are  evenly 
distributed2.
Schein et  al  in  their  study on emergency operations for  perforated 
ulcers, divided their patients based on APACHE II score, into two groups – 
those with low risk (score < 10) and those with high risk (score >10). They 
found that the mortality rate in the low risk patients was only 8% whereas it 
was  33.3%  in  the  patients  with  a  score  >1015.  Similar   stratification  of 
patients was done in numerous other studies9,16,17,18.
2.     Quality of care measurement:
 At the costs of medical care, especially hospital care have increased, 
quality  assessment  has  become  a  major  priority  for  ICUs,  government 
hospitals, and third party payers. Not adjusting mortality and complication 
rates for risks before treatment, however, is an insensitive way to assess a 
hospital’s or an ICU’s performance. A suburban shock and trauma unit will 
have a far different patient population than a inner city ICU. A prognostic 
scoring system that establishes a predicted mortality rate before treatment 
for an ICU on the basis of patient-by-patient measurement of risk will permit 
the ICUs to compare the predicted outcome to its observed outcome. The 
difference between predicted and actual death rates is one direct measure of 
quality of care and this technique can also provide unique insights regarding 
the usefulness of specific treatments.
Michael Marsh et al in 1990, in a study conducted to assess prediction 
of  mortality by using the APACHE II  scoring system in ICUs, observed 
that the predicted risk for hospital  death among non-operative patients in 
Rochester  Methodist  Hospital  was  significantly  higher  than  the  risk 
predicted at Saint Mary’s Hospital. Further evaluation revealed that both the 
groups of patients had similar mean ages. When the APACHE II scores were 
examined,  they  observed  that  the  mean  acute  physiology  score  of  the 
patients at Rochester Methodist Hospital was significantly higher than the 
score observed at Saint Mary’s Hospital19.
Knaus and co-workers in 1982, in a study comparing the outcome of 
acutely ill patients treated in French and American ICUs, observed that for 
patients with severe gastrointestinal disorders, the French hospital death rate 
was  significantly  higher  than  the  one  predicted  in  American  hospitals. 
Investigations into this discrepancy led to the conclusion that the disparity 
may have been due in part to a more aggressive surgical approach to acute 
pancreatitis in France20.
3.      Allocation of Resource:
An important  issue fore very ICU is in deciding which patients  to 
admit.  Because cost containment dominates health care policy, we would 
like  to  improve  patient  selection  to  ICU  care.  An  objective  method  to 
identify  the  relative  risk  of  patients  might  be  useful  to  support  clinical 
judgement and to establish priorities for ICU admission during the periods 
of limited bed availability2.
Yet another important issue is to determine which patients have 100% 
mortality and further aggressive therapy would be futile.
     Borlase  et  al  in  their  study  conducted  in  1990,  suggested  that  an 
APS>25, a Glasgow coma score < 7 and a creatinine > 4.5 mg/dl were good 
predictors of mortality on the first day of ICU admission. This study did not 
demonstrate  an  enhanced  predictive  power  with  sequential  APACHE 
scoring as shown by trend analysis. In considering the daily cost of predicted 
SICU non-survivors  ($  1500/day),  if  treatment  had been stopped  after10 
days  of  aggressive  therapy  with  no  improvement,  the  potential  savings 
would have reached almost $ 250,000 or 4% of the total cost for the 100 
patients studied21.
4.     Statistical versus clinical judgement:
One of the interesting aspects of the uses of the scoring systems is a 
comparison of the expectations that physicians and patients have regarding 
their prognosis and how their clinical and personal assessments compare to 
probabilities produced by the application of prognostic scoring systems.
      Kruse and associates found that there were no substantial differences 
in  accuracy  between  the  APACHE  scores  at  ICU  admission  and  the 
assessment made by ICU physicians and nurses. But, there was a significant 
disagreement regarding the outcome of 40% of the admissions between the 
physicians and the nurses22.
       Meyer and his associates observed that clinical assessment is superior 
to  APACHE  II  in  predicting  outcome  in  critically  ill  surgical  patients, 
although  the  difference  was  small.  A  similar  observation  was  made  by 
Marks  and his  associates  in  a  patient  population  that  comprised  of  both 
medical  and  surgical  patients.  But,  they  observed  that  although  the 
predictions could be successfully applied to the population as a whole, none 
of the tests were suitable for predicting outcome on an individual patient24.
5.      Individual Patient care decisions:
For many clinicians, the most important question regarding prognostic 
scoring system is how they can help with individual patient care decisions. 
Prognostic scoring systems will never be able to predict outcome with 100% 
specificity, but accurate risk estimates of death or complications at the 90 to 
99% level  could  be  useful.  Before  clinicians  actually  integrate  such risk 
estimates into their practice, however, they should consider the implications 
of a risk prediction for an individual patient. The argument frequently used 
is  that  group  statistics  do  not  apply  to  single  individuals.  Although 
individual patients do have unique features they also share many common 
features  with  previous  patients  and  consideration  of  these  common 
characteristics  permits  us  to  anticipate  their  response  and  predict  their 
outcome. Moreover, if probabilities did not have a role in clinical decision-
making, then we would never be able to use past experience to guide future 
decisions.
      Prognostic  scoring  systems  can  assist  us  in  ensuring  that  clinical 
predictions  are  well  calibrated  and  accurate  for  a  patient.  Because  they 
estimate  a  patient’s  potential  to  benefit  from  therapy,  they  are  also 
estimating, in an unbiased manner, an individual’s comparative entitlement 
to medical care2.  
       Singh and his associates used APACHE II scoring system to define 
their  patients  in whom they studied the role of  zipper  laparotomy in the 
management of abdominal sepsis. They defined the patient group as those 
having an APACHE II score range of 27-3025.
       Schein and his associates utilized the APACHE II score in choosing 
the type of surgery to be performed in their patients with perforated ulcers. 
In chronic duodenal ulcer patients, definitive surgery was performed only if 
the APACHE II score was below 11, whereas those with higher scores were 
subjected  to  simple  closure.  Likewise  in  patients  with  perforated  gastric 
ulcers,  closure or  wedge excision of the ulcer  was elected,  if  technically 
feasible; in the high-risk group (APACHE II score > 10). In the low-risk 
group (score <11), truncal vagotomy and antrectomy or partial gastrectomy 
were  performed  for  ulcers  situated  in  the  prepyloric  region  or  the  body 
respectively15.
LIMITATIONS OF PROGNOSTIC SCORING SYSTEMS
The use of prognostic scoring systems for  clinical  decision-making 
raises many ethical, philosophical and practical issues. The most important 
practical requirements are that its predictions must approach infallibility and 
it  must  be  reproducible.  The  original  APACHE  II  score  used  a  single 
assessment on first day of ICU admission. While this had been shown to be 
an excellent method for stratifying patients into comparable risk groups for 
audits or clinical trials, it is inadequate for predicting individual prognosis 
for several theoretical and practical reasons.
1. It  does  not  reflect  the  dynamic  pathophysiological  changes  that 
occur during the patient’s stay in the ICU.
2. Although the APACHE II score with the exception of neurologic 
points  is  based on objective  data,  derivation of  risk of  death is 
based  on  a  subjective  choice  of  a  single  specific  diagnostic 
category  or  major  organ  system  as  the  primary  cause  of  ICU 
admission.  The  correct  choice  can  sometimes  be  extremely 
difficult  to make,  especially among patients with multiple organ 
system  failure  and  high  mortality  rates,  precisely  the  group  of 
patients in whom a correct prediction is important.  An incorrect 
choice  can  lead  to  a  wrong  computation  of  risk  of  death  and 
therefore, a wrong prediction.
3. Therefore,  it  would  be  unacceptable  to  clinicians,  patients  and 
relatives to base major clinical decisions on just one assessment26.
Hence,  further  research  and  analysis  is  required  to  arrive  at  the 
ultimate goal of developing ideal and 100% infalliable prognostic system. 
AIMS AND OBJECTIVES
The following were the aims and objectives of the study:
1. To stratify  the  patients  with  generalized  peritonitis  based  on  their 
scores at admission.   
2. To correlate the mortality rates observed with the scores.  
3. To correlate the various postoperative outcomes observed with the 
scores.           
PATIENTS AND SCORING
One hundred and forty patients of acute generalized peritonitis, treated 
in Government Rajaji Hospital between December 2004 to February 2006, 
were studied prospectively. Children below 14 years were excluded from the 
study. All cases with either primary peritonitis or that due to anastomotic 
dehiscence were excluded.
Clinical  evaluation  as  well  as  hematological  and  biochemical 
investigations were carried out. Patients were treated with intravenous fluid 
and correction of electrolyte imbalance as indicated by the results of serum 
electrolytes  and  urea.  Urethral  catheter  was  inserted  to  monitor  hourly 
urinary output and naso-gastric  tube inserted to decompress  the stomach. 
The parameters of modified APACHE II were assessed and recorded at the 
time of admission.
Modified APACHE II scoring:
Modified  APACHE II  scoring  system  is  a  simplified  form of  the 
original  APACHE  II  scoring.   The  following  Acute  Physiological 
parameters of APACHE II are included –temperature, mean arterial blood 
pressure, heart rate, respiratory rate, serum sodium,  potassium, creatinine, 
bicarbonate, haematocrit and white blood cell count. Arterial pH and arterial 
oxygenation of APACHE II was omitted in this modified scoring. Agarwal 
and his associates have proved that “arterial pH and arterial oxygenation are 
not essential for risk stratification in perforation peritonitis” in their study28.
The scores ranged from 0 to 4 on each side of normal value. Zero 
score represents normal values, an increase to 4 indicating the extreme end 
of high or low abnormal levels. Included in this study as a part of Acute 
Physiological  Score  was  the  serum  urea.  This  was  scored  using  the 
paratmeter  similar  that  of  serum  creatinine  as  follows:  serum  urea  15 
mmol/L = 4, 9-14 mmol/L =3, 5-8 mmol/L = 2, 1.4-4 mmol/L = 0, 1-1.39 
mmol/L =1, <1 mmol/L =2.
Age points are as follows for adult patients:
44 = 0; 45-54=2; 55-64 =3; 65-74 =5; >74=6.
         Chronic ill health score assigned as follows:
.  For non-operative or emergency postoperative patients – 5
. Elective postoperative patients – 2
        Organ insufficiency or  immuno-compromised state must  have been 
evident prior to hospital admission and conform to following criteria:
- Liver  :  Biopsy  proven  cirrhosis  and  documented  portal 
hypertension  or  prior  episodes  of  hepatic  failure, 
encephalopathy or coma.
- CVS  : New York heart Association Class IV
- RS  :  Chronic  restrictive,  obstructive  or  vascular  disease 
resulting  in  severe  exercise  restriction,  chronic  hypoxia, 
hypercapnea,  severe  polycythemia,  severe  pulmonary 
hypertension or respiratory dependency.
- RENAL  : Receiving chronic dialysis
- IMMUNO-COMPROMISED  :  The  patient  has  received 
therapy  that  suppresses  resistance  to  infection.  E.g.: 
immunosuppression,  chemotherapy,  radiation,  long  term  or 
recent steroids, or has a disease that is sufficiently advanced 
in suppress resistance to infection. E.g.: leukemia, lymphoma, 
AIDS. 
After  adequate  resuscitation  and  assessment,  patients  underwent 
exploratory  laparatomy  in  emergency  setting.  At  surgery  the  source  of 
contamination  was  sought  for  and  controlled.  The  peritoneal  cavity  was 
irrigated with 5-6 litres of warm normal saline and the decision to insert a 
drain  was  left  to  the  discretion  of  the  operating  surgeon.  Abdomen  was 
closed  with  continuous,  number  one  non-absorbable  suture  material. 
Although all  patients received appropriative perioperative broad spectrum 
antibiotics, the drug regimen was not uniform.
ANALYSIS:
  Demographic,  clinical,  preoperative,  and  /or  postoperative 
complications data on each patient were entered into a standard profoma. 
Each  patient’s  postoperative  outcome  /  mortality  were  compared  to 
determine  the  significance  of  the  severity  of  illness  on  postoperative 
complications and mortality.
MODIFIED APACHE II SCORING
PHYSIOLOGIC VARIABLE 4 3
Temperature rectal(oC) ≥41 39-40.9
Mean arterial pressure (mmHg) ≥160 130-159
High rate (ventricular response) ≥150 140-179
Respiratory rate ≥50 35–49
Serum sodium mMol/L ≥180 160-179
Serum potassium mMol/L ≥3.5 2-3.4
Haemtocrit % ≥60
WBC x 1000 (total mm3) ≥40
Serum HCO3 Venous blood mMol ≥52 41-51.9
Serum Urea mMol/L >15 9–14
   
AGE POINTS:  <44 = 0; 45-54 = 2; 55-64 = 3; 65-74 = 5; ≥75 =  6.
Chronic ill-health evaluation (severe organ insufficiency) Points:  presence of chronic illness requiring the following :
(a)    for non-operative or emergency postoperative patients – 5
               (b) for elective postoperative patients – 2 
One  hundred  and  forty  patients  of  generalized  peritonitis  were 
prospectively studied during the period form December 2004 to February 
2006.
AGE GROUP AFFECTED:
Age  ranged  from  16  years  to  80  years  with  the  mean  age  of 
39.92 ± 12.18. In this study, majority of the patients belonged to 36-45 years 
age group, followed by 46-55 years age group.
Age in years No. of patients Percentage
16-25 16 11 %
26-35 32 23 %
36-45 49 35 %
46-55 33 24 %
56-65 7 5 %
>65 3 2 %
  SEX INCIDENCE:
   
   Gender No. of patients Percentage
    Male 121 86 %
    Female 19 14 %
    uTotal 140
 Among 140 cases studied, there were 121 male cases, and 19 female 
cases, and male: female ratio was 6.4: 1
CLINICAL PRESENTATION:
The  clinical  presentation  of  the  patients  varied  according  to  the 
pathology.  The patient  of  duodenal  ulcer  perforation  usually  had a  short 
history  of  pain  starting  in  epigastrium  or  upper  abdomen  along  with 
generalized  tenderness  and  guarding.  The  patients  with  small  bowel 
perforation  presented  with  prolonged  history  of  fever  followed  by  the 
appearance  of  pain  in  lower  abdomen  associated  with  vomiting  or 
constipation. Clinical examination revealed abdominal distension. Only 50% 
had evidence of pnumoperitoneum on chest X-ray done in erect posture.
 Appendicular  perforations  had  characteristic  pain  starting  in  the 
periumblical area or right iliac fossa along with vomiting and fever. None of 
the  patients  of  appendicular  perforation  showed  evidence  of  gas  under 
diaphragm on erect Chest X-ray.
 In majority of the cases the presentation to the hospital is late with 
well established generalized peritonitis with purulent of fecal contamination 
and varying degrees of septicemia. The signs and symptoms are typical and 
it is possible to make a clinical diagnosis of peritonitis in all patients.
CAUSES OF PERITONITIS:
       The commonest cause of peritonitis was perforation of the duodenal 
ulcer,  which  was  found  in  68%  of  patients.  Other  causes  were  ileal 
perforation in  9% cases,  gastric  perforation in  6% cases,  gangrene small 
bowel in 5% cases, colonic perforation in 2% cases. Other rare causes are 
ruptured liver abscess (1%) , perforation -? unknown cause (3.1%) cases.
ETIOLOGY NO. OF PATIENTS PERCENTAGE
Duodenal Ulcer Perforation 95 68 %
Ileal perforation 12 9 %
Appendicular perforation 9 6 %
Gastric Perforation 9 6 %
Gangrene gut 7 5 %
Colon perforation 3 2 %
Other causes 5 4 %
The perforation of proximal gastrointestinal tract was five times as 
common as perforations of distal gastrointestinal tract.
POST-OPERATIVE COMPLICATIONS:
   55 patients incurred postoperative complications in this study, and the 
morbidity  rate  was  46%.  The  following  table  shows  the  postoperative 
complications in patients who underwent laparotomy (patients who expired 
were excluded).
COMPLICATIONS NO. OF PATIENTS PERCENTAGE
Wound infection 54 45 %
Wound dehiscence 12 10 %
Respiratory complications 19 16 %
Intra-abdominal abscess 16 13 %
Entero-cutaneous fistula 5 4 %
HOSPITAL STAY:
       The mean range of stay of patients in the hospital ranged from 10-14 
days.  The following table shows the duration of hospital  stay of patients 
with generalized peritonitis, excluding those who died.
NO. OF DAYS NO. OF 
PATIENTS
PERCENTAGE
< 10 26 22 %
10 - 14 67 56 %
15 – 19 15 13 %
20 – 24 7 6 %
> 24 4 3 %
MODIFIED APACHE II SCORES:
    Modified APACHE II scores at the time of admission ranged from 
0 to 29. The mean score in survivors was 5.32 ± 4.72. The mean score in 
non-survivors was 14.24 ± 5.50.
STATUS NO. OF PATIENTS PERCENTAGE MEAN SCORE 
Overall 140 - -
Survivors 119 85 % 5.32 ± 4.72
Non-survivors 21 15 % 14.24 ± 5.50
Patients were stratified into four groups according to their scores at 
admission (0-4; 5-9; 10-14; >14).
SCORES TOTAL PERCENTAGE SURVIVORS NON-SURVIVORS
TOTAL PERCENTAGE TOTAL PERCENTAGE
0 - 4
59 42 % 59 42 % -
5 – 9
39 28 % 35 25 % 4 3 %
10- 14
27 19 % 19 14 % 8 6 %
> 14
15 11 % 6 4 % 9 6 %
Total
140 - 119 85 % 21 15 %
                                                                                 
MORTALITY:
21  patients  with  generalized  peritonitis  died  in  the  present  study. 
Overall  mortality  rate  in  this  study  was  15%.  Among  those  suffered 
mortality 18 were males, and 3 were females. 17 patients belonged to the 
operative group and died in the postoperative period, and 4 patients died in 
the preoperative period during resuscitation.
       There  were  no  death  among  patients,  who  scored  0-4,  whereas 
mortality was 10.25% in those who scored 5-9, 29.6% in those who scored 
10-14, and 60% in patients who scored >14.
SCORES NO. OF PATIENTS EXPIRED MORTALITY
0 – 4 59 - -
5 – 9 39 4 10.25%
10 – 14 27 8 29.6%
> 14 15 9 60%
TOTAL 140 21 15%
x2= 27.76
p = 0.0001
There is a significant association between the modified APACHE II 
scores and the mortality.
POST-OPERATIVE OUTCOMES:
WOUND INFECTION:
The most common postoperative complication was wound infection. 
Wound infection was seen in 54 patients (40%) in the present study (patients 
who died were excluded). Wound infection was 34% among patients who 
scored 0-4, whereas 54% in those who scored 5-9, 68% in those who scored 
10-14, and 33% in patients who scored >14. 
SCORE
WOUND INFECTION
PRESENT ABSENT
NO. % N0. %
0 – 4 20 34 39 66
5 – 9 19 54 16 46
10 – 14 13 68 6 32
> 14 2 33 4 77
TOTAL 54 - 65
x2= 2.03
p = 0.1538
There was no statistically significant association between the modified 
APACHE II scores and the wound infection.
WOUND DEHISCENCE:
       
       Overall  incidence  of  wound  dehiscence  was  11%  (13  patients). 
Patients with wound dehiscence had a mean score of  6.69 ± 4.46. Wound 
dehiscence was 7% among patients who scored 0-4, whereas 14% in those 
who scored 5-9, 16% in those who scored 10-14, and 17% in patients who 
scored >14. 
SCORE
WOUND DEHISCENCE
PRESENT ABSENT
NO. % N0. %
0 – 4 4 7 55 93
5 – 9 5 14 30 86
10 – 14 3 16 16 84
> 14 1 17 5 83
TOTAL 13 - 106 -
x2= 0.3054
p = 0.22
         
Wound  dehiscence  does  not  have  significant  association  with 
modified APACHE II scores (p=.22)
RESPIRATORY COMPLICATIONS:
        The  respiratory  complications  were  pneumonia,  atelectasis,  pleural 
effusion,etc. In this study, 19 patients had respiratory complications (16%); 
and the mean score was 7.26 ± 4.15. Respiratory complication was 10% 
among patients who scored 0-4, whereas 23% in those who scored 5-9, 26% 
in those who scored 10-14, and nil in patients who scored >14. 
SCORE
RESPIRATORY COMPLICATIONS
PRESENT ABSENT
NO. % N0. %
0 – 4 6 10 53 90
5 – 9 8 23 27 77
10 – 14 5 26 14 74
> 14 - - 6 100
TOTAL 19 100
x2= 0.1
p = 0.3637
Modified  APACHE II  score  does  not  have  statistically  significant 
association with the postoperative respiratory complications.
INTRA-ABDOMINAL ABSCESS:
      
       Intra-abdominal  abscess/sepsis  was  seen in  16 patients  (13%).  The 
mean score was 8.88 ± 4.5. Intra-abdominal abscess was 5% among patients 
who scored 0-4, whereas 26% in those who scored 5-9, 21% in those who 
scored 10-14, and 33% in patients who scored >14. 
SCORE
INTRA-ABDOMINAL  ABSCESS
PRESENT ABSENT
NO. % N0. %
0 – 4 3 5 56 95
5 – 9 7 26 28 80
10 – 14 4 21 15 79
> 14 2 33 4 67
TOTAL 16 103
x2= 1.99
p = 0.0839
There  is  no  statistically  significant  association  between  the  intra-
abdominal abscess and the modified APACHE II scoring.
ENTERO-CUTANEOUS FISTULA:
Entero-cutaneous fistula was seen in 4 patients (3%); and their mean 
score was 7.8 ±5.69. Entero-cutaneous fistula was 2% among patients who 
scored 0-4, whereas 9% in those who scored 5-9, 5% in those who scored 
10-14, and nil in patients who scored >14. 
SCORE
ENTERO-CUTANEOUS FISTULA
PRESENT ABSENT
NO. % N0. %
0 – 4 1 2 58 98
5 – 9 3 9 32 91
10 – 14 1 5 18 95
> 14 - - 6 100
TOTAL 4 114
x2= 0.25
p = 0.7178
No statistically significant association was seen between the entero-
cutaneous fistula and the modified APACHE II scores.
            
HOSPITAL STAY:
The duration of the hospital stay ranged from 7 – 60 days, with the 
mean duration ranging from 10 -14 days.
There is no statistically significant association between the modified 
APACHE II scoring and the duration of hospital stay, which is an important 
indicator of postoperative morbidity.
DISCUSSION
Acute  generalized  peritonitis  is  a  common  surgical  emergency  in 
many surgical units in the developing countries. It is often associated with 
high  morbidity  and  mortality.  Mortality  following  acute  generalized 
peritonitis is around 16-40% with many having to face with severe wound 
infection and wound dehiscence. Mortality rate of 15% was recorded in this 
study.
Males were predominantly affected in this study, and male:  female 
ratio  6.4:1.  The  commonest  age  group  affected  was  36-45  years,  as 
compared to the studies in the west, where the mean age group is between 45 
– 60 years.
In majority of the cases the presentation to the hospital is late with 
well established generalized peritonitis with purulent of fecal contamination 
and varying degrees of septicemia. The signs and symptoms are typical and 
it is possible to make a clinical diagnosis of peritonitis in all patients.
The perforation of proximal gastrointestinal tract were five times as 
common as perforations of distal gastrointestinal tract as has been noted in 
earlier  studies  from  India,  which  is  in  sharp  contrast  to  studies  from 
developed  countries,  which  revealed  that  distal  gastrointestinal  tract 
perforations were more common. 
     The most  common cause of peritonitis in our study was perforated 
duodenal  ulcer  (95  cases)  followed  by  ileal  perforation  (12  cases), 
appendicular  perforation  (9  cases),  gastric  perforation  (9  cases).  Despite 
delay in seeking treatment, the overall mortality rate (15%) was favorably 
comparable with other published series though the overall morbidity (46%) 
was unusually high.
The  objective  evaluation  of  severity,  therapeutic  approach  and 
effectiveness of treatment of acute generalized peritonitis is hampered by 
lack  of  precise  classification  in  this  environment.  Crude  morbidity  and 
mortality data for the purpose of medical audit is often misleading. Early 
prognostic evaluation is desirable to be able to select high risk patients for 
more aggressive treatment especially in severe peritonitis.
APACHE II scores have been shown to have a stronger relationship to 
the  outcome  than  previous  groupings  such  as  anatomy,  causes,  age  and 
chronic  ill  health  without  consideration  for  systemic  effect  of  the  intra-
abdominal  sepsis,  thus  its  use  in  this  study.  APACHE  II  score  is  very 
popular and has been used in both surgical and non-surgical patients; it has 
also been validated using many patients over several years in many centers 
in the developed countries.
Of the present prognostic scoring systems, APACHE II appeared to be 
the most widely used and had a general acceptance in assessing the critically 
ill patients for its easy applicability and ability to predict outcome. Many of 
the patients have associated high APACHE II scores with poor outcome as 
previously documented and confirmed by this study.
The present study confirmed the ability of modified APACHE II score 
to predict mortality in acute peritonitis sepsis. The study also showed that it 
could be easily applied to grade the severity of acute generalized peritonitis 
in  centres  like  ours,  despite  inadequate  facilities,  with  some  degree  of 
effectiveness.  There  was  no  death  among  the  patients  who  scored  0-4; 
whereas mortality was 10.25% in patients who scored 5-9; 26.9% in patients 
who scored 10-14; 60% in patients who scored >14. This study thus showed 
the  significant  association  of  the  modified  APACHE  II  score  and  the 
prediction of mortality.
The major cause of postoperative morbidity was wound infection seen 
in 40% patients. The incidence of surgical site infection increases with the 
degree of contamination;  therefore, surgical site infection occurs at  much 
higher rates after operations for peritonitis and peritoneal abscess. Surgical 
site infection may be expected if  wound is closed in the setting of gross 
abdominal  contamination.  Perioperative  systemic,  antibiotics,  the  use  of 
wound protector devices, and lavage of the wound at the end of therapy do 
not reliably prevent this complication. These wounds should be left open and 
be treated with wet-to-dry dressing changes several  times a day or  VAC 
dressing should be applied.
Other  than  wound  infection,  the  most  common  abdominal 
complication is wound dehiscence in FORREST’S view, and in this study 
next  to  wound  infection  is  wound  dehiscence.  Wound dehiscence  is  the 
reflection of both the high incidence of infection and debility of the patients. 
Unacceptably  high  incidence  of  wound  dehiscence  (12%)  in  the  present 
series was multifactorial due to delayed presentation, gross contamination of 
the peritoneal cavity and septicaemia. Just like dehiscence, the development 
of fecal fistula is catastrophic and should be addressed aggressively.  This 
complication was seen in 5 patients (3%).
Respiratory complication was the second most common complication 
in this study. It was present in 19 patients. The duration of hospital stay, 
which is one of the indicators for morbidity, ranged from 7 to 60 days. The 
mean duration of hospital  stay was 10-14 days. There was no significant 
association of the various postoperative complications and the hospital stay 
duration.  Thus  the  ability  of  modified  APACHE II  scores  to  predict  the 
postoperative morbidity could not be confirmed by this study.
CONCLUSION
- Among  the  patients  studied,  duodenal  ulcer  perforation  was  the 
commonest cause for generalized peritonitis.
- Predominance of male over female in acute generalized peritonitis 
with the ratio of 6.4:1
- People  in  the  age  group  of  3rd and  4th decade  were  commonly 
involved in generalized peritonitis.
- Overall mortality in patients with generalized peritonitis was 15%.
- Modified APACHE II scores predicted the mortality in the patients 
with acute generalized peritonitis.
- Modified  APACHE II  scores  could  not  predict  the  incidence  of 
postoperative complications
In this study, we conclude that modified APACHE II score would be 
an easy grading for the evaluation of disease severity in patients with acute 
generalized peritonitis.
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PROFORMA
Name:                                                               Age / Sex:
Occupation:                                                     IP No:
Address:
Date of admission:
Date of surgery:
Date of discharge:
CLINICAL FEATURES:
                       Pain Abdomen:                    hrs / days 
                       Drug intake      :                    Yes / No
                       H/O Smoking / Alcohol intake
                       Associated systemic illness:  Yes / No
                        (DM / HT / CAHD / COPD / Malignancy / renal failure / liver disorder)
                       Peritonitis:     - diffuse and generalized
                                               - localized rigidity
PARAMETERS OF MODIFIED APACHE II SCORING
ACUTE PHYSIOLOGICAL SCORES:
N
O
PARAMETERS
VALUES SCORING
1. Temperature (*C)
2. Heart rate
3. Respiratory rate
4. Mean arterial pressure (mmHg)
5. Haematocrit (%)
6. WBC count (total / mm3)
7. Serum sodium (mMol / L)
8. Serum potassium (mMol /L)
9. Serum bicarbonate (mMol /L)
10. Serum creatinine (mg / 100ml)
11. Serum urea (mg / 100ml)
 AGE SCORE                                                                                                    ______________
CHRONIC ILL HEALTH SCORE                                                                  ______________
TOTAL SCORE                                                                                                ______________
OTHER INVESTIGATIONS:
               - Blood Hb            :
               - Blood sugar        :
               - Blood G&T        :
               - Imaging              :
               - Others                :
TREATMENT:
               - Procedure done: Simple Omental Patch Closure / Bilateral flank drainage /
                                             Bilateral flank drainage followed by surgery.
               - Time interval between admission and intervention:
- FINDINGS:
  POST-OPERATIVE OUTCOME:
• Wound infection
• Wound dehiscence
• Residual intra-abdominal abscess
• Respiratory complications
• Enterocutaneous fistula
• Hospital stay
• Death
• Others
